We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 70 results
  1. Investigation of the Anti-asthmatic Activity of Solidagenone, In Vitro Toxicity Versus In Silico Studies

    Solidagenone, a labdane diterpene isolated from inflorescences of Solidago chilensis Meyen, Asteraceae, was investigated for its anti-inflammatory...

    Deise Cristina Drummond Xavier Paes Lopes, Thais Morais de Brito, ... Eduardo Ricci Junior in Revista Brasileira de Farmacognosia
    Article 15 November 2023
  2. Regulatory Considerations Toward Orphan Drug Designation and Orphan Drug Exclusivity in the United States and European Union: Structural Similarity, Clinical Superiority/Significant Benefit, and Case Studies

    The U.S. Food and Drug Administration and European Commission have developed successful orphan drug legislation to promote the research, development,...

    Scott W. Roberts, Tara Laura Brandt Elvang, ... Tue Anker Mikkelsen in Therapeutic Innovation & Regulatory Science
    Article 18 November 2022
  3. Physical Chemistry

    Many pharmaceutical dosage forms are liquids or semi-liquids such as solutions, colloidal systems, suspensions and emulsions. This chapter deals with...
    Wouter Hinrichs, Renske van Gestel in Practical Pharmaceutics
    Chapter 2023
  4. Translational Biomarkers: Application in the Clinical Development of Combination Therapies

    Development of appropriate pharmacodynamic and safety markers early in drug development can result in a higher probability of success for new drug...
    Selvakumar Sukumar, Niña G. Caculitan in Development of Antibody-Based Therapeutics
    Chapter 2018
  5. Gallic and Vanillic Acids as Promising Succinate Dehydrogenase Inhibitors and Antigenotoxic Agents

    The influence of gallic and vanillic acids in the activity of succinate dehydrogenase employing in silico and in vitro analyses was evaluated....

    Tatiane Silva de Abreu, Mariana Aparecida Braga, ... Silvana Marcussi in Revista Brasileira de Farmacognosia
    Article 17 December 2021
  6. Concepts and Strategies in the Design of Formulations for Freeze Drying

    In order to enhance the storage stability of water labile molecules the common practice is to employ lyophilization (freeze drying) process to create...
    Chapter 2023
  7. Molecular Dynamics Simulation Study of N-14 Side Chain Substituted Styelsamines Binding to DNA

    N-14 side chain substituted marine styelsamines are synthesized ligands that have been evaluated for DNA binding and antitumor activity. Experimental...

    Mohsen Sargolzaei in Pharmaceutical Chemistry Journal
    Article 24 February 2020
  8. Design and Discovery of 3,6-Substituted 1,2,4,5-Tetraoxanes as New Class of Falcipain-2 Inhibitors for Antimalarial Action

    A new series of tetraoxanes were developed and screened for in vitro antimalarial activity against chloroquine sensitive strains of Plasmodium...

    Mukesh Kumar Kumawat, Udaya Pratap Singh, Dipak Chetia in Pharmaceutical Chemistry Journal
    Article 05 December 2019
  9. Assessing Real-World Data Quality: The Application of Patient Registry Quality Criteria to Real-World Data and Real-World Evidence

    The use of real-world data and real-world evidence to inform health care decisions is increasing. Yet, the variable quality of these data and the...

    Richard E. Gliklich, Michelle B. Leavy in Therapeutic Innovation & Regulatory Science
    Article 06 January 2020
  10. Antitumor effects of berberine against EGFR, ERK1/2, P38 and AKT in MDA-MB231 and MCF-7 breast cancer cells using molecular modelling and in vitro study

    Background

    Berberine is an alkaloid plant-based DNA intercalator that affects gene regulation, particularly expression of oncogenic and tumor...

    Parham Jabbarzadeh Kaboli, Melody Pui-Yee Leong, ... King-Hwa Ling in Pharmacological Reports
    Article 01 August 2018
  11. Natural products assessed in animal models for orofacial pain — a systematic review

    Orofacial pain is related to tissues of the head, face, neck and all the intraoral structures; it is rather debilitating to the patient and also...

    Pollyana S. Siqueira-Lima, Juliane C. Silva, ... Lucindo J. Quintans-Júnior in Revista Brasileira de Farmacognosia
    Article Open access 01 February 2017
  12. Chronic antidepressant-like effect of EMD386088, a partial 5-HT6 receptor agonist, in olfactory bulbectomy model may be connected with BDNF and/or CREB signalling pathway

    Background

    The removal of the olfactory bulbs has been attributed to behavioral changes and neuroplasticity manifesting themselves among others like...

    Magdalena Jastrzębska-Więsek, Joanna Gdula-Argasińska, ... Anna Wesołowska in Pharmacological Reports
    Article 24 May 2018
  13. New Thomimarine E from Marine Isolate of the Fungus Penicillium thomii

    The new eudesmane-type sesquiterpene thomimarine E ( 1 ) and the known compounds guaiadiol A ( 2 ) and 4,10,11-trihydroxyguaiane ( 3 ) were isolated from...

    Sh. Sh. Afiyatullov, E. V. Leshchenko, ... D. V. Berdyshev in Chemistry of Natural Compounds
    Article 01 March 2017
  14. Assessing the Financial Value of Patient Engagement: A Quantitative Approach from CTTI’s Patient Groups and Clinical Trials Project

    Background

    While patient groups, regulators, and sponsors are increasingly considering engaging with patients in the design and conduct of clinical...

    Bennett Levitan, Kenneth Getz, ... Joseph DiMasi in Therapeutic Innovation & Regulatory Science
    Article Open access 01 March 2018
  15. Assessment of 5-substituted Isatin as Surface Recognition Group: Design, Synthesis, and Antiproliferative Evaluation of Hydroxamates as Novel Histone Deacetylase Inhibitors

    Histone deacetylase (HDAC) is a promising target for cancer treatment. HDAC inhibitors consist of three pharmacophoric features: an aromatic cap...

    Avineesh Singh, Kamlesh Raghuwanshi, ... Harish Rajak in Pharmaceutical Chemistry Journal
    Article 01 August 2017
  16. Public- and Private-Sector Contributions to the Research and Development of the Most Transformational Drugs in the Past 25 Years: From Theory to Therapy

    Background

    With available funding from the public sector decreasing while medical needs and scientific complexity increase, private-sector...

    Ranjana Chakravarthy, Kristina Cotter, ... Nils Wendel in Therapeutic Innovation & Regulatory Science
    Article 01 November 2016
  17. Applying Regulatory Science to Develop Safe and Effective Medicines for Neonates: Report of the US Food and Drug Administration First Annual Neonatal Scientific Workshop, October 28–29, 2014

    The First Annual Neonatal Scientific Workshop focused on the needs of the neonate by addressing the basic question: what information is required to...

    Martin Offringa, Jonathan M. Davis, ... Robert M. Nelson in Therapeutic Innovation & Regulatory Science
    Article 01 September 2015
  18. Potential role of spinal TRPA1 channels in antinociceptive tolerance to spinally administered morphine

    Background

    Prolonged morphine treatment leads to antinociceptive tolerance. Suppression of spinal astrocytes or d -amino acid oxidase (DAAO), an...

    Hong Wei, Hai-Yun Wu, ... Antti Pertovaara in Pharmacological Reports
    Article 14 December 2015
  19. Molecular Dynamics Simulation Approach to Understand Lamivudine Resistance in Hepatitis B Virus Polymerase

    Hepatitis B virus (HBV) is a global threat that killed many human lives. HBV DNA polymerase (HDP) is the key target for antiviral drug treatment. The...

    M. Srividhya, K. Ramanathan in Pharmaceutical Chemistry Journal
    Article 30 October 2015
  20. A Model Data Management Plan Standard Operating Procedure: Results From the DIA Clinical Data Management Community, Committee on Clinical Data Management Plan

    Background

    The DIA Clinical Data Management Community created a committee to develop a model standard operating procedure (SOP) for writing a data...

    Scott Brand, Diana Bartlett, ... Kristin Neff in Therapeutic Innovation & Regulatory Science
    Article 01 September 2015
Did you find what you were looking for? Share feedback.